openPR Logo
Press release

Lassa Fever Pipeline| Clinical Trials, Key Companies - Themis Bioscience, Inovio, GeoVax, GloBavir biosciences, and Kineta Inc

11-06-2023 11:11 AM CET | Health & Medicine

Press release from: DelveInsight Business Research LLP

Lassa Fever Pipeline

Lassa Fever Pipeline

DelveInsight's, "Lassa Fever - Pipeline Insight, 2023," report provides comprehensive insights about companies and pipeline drugs in the Lassa Fever pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.

Download Sample Report to know more
@ https://www.delveinsight.com/report-store/lassa-fever-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=dpr

Lassa Fever Overview
Lassa fever, also known as Lassa hemorrhagic fever, is a type of viral hemorrhagic fever caused by the Lassa virus. Many of those infected by the virus do not develop symptoms. When symptoms occur they typically include fever, weakness, headaches, vomiting, and muscle pains. Less commonly there may be bleeding from the mouth or gastrointestinal tract. The risk of death once infected is about one percent and frequently occurs within two weeks of the onset of symptoms. Of those who survive, about a quarter have hearing loss, which improves within three months in about half of these cases.
The disease is usually initially spread to people via contact with the urine or feces of an infected multimammate mouse. Spread can then occur via direct contact between people. Diagnosis based on symptoms is difficult. Confirmation is by laboratory testing to detect the virus's RNA, antibodies for the virus, or the virus itself in cell culture. Other conditions that may present similarly include Ebola, malaria, typhoid fever, and yellow fever. The Lassa virus is a member of the Arenaviridae family of viruses.

Click here to learn more about the Lassa Fever Market Landscape @https://www.delveinsight.com/report-store/lassa-fever-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=dpr

Key Highlights from Lassa Fever Pipeline Report
Key Companies working in Lassa Fever Include Curevac AG, Themis Bioscience, Inovio, GeoVax, GloBavir biosciences, and Kineta Inc.
Key Therapies working in Lassa Fever includes INO-4500, MV-LASV, LHF 535, and many others.

DelveInsight's report covers products under different phases of clinical development like
Early-stage products (Phase I/II and Phase I) along with the details of
Pre-clinical and Discovery stage candidates
Discontinued and inactive candidates
Route of Administration

Lassa Fever pipeline report provides the therapeutic assessment of the pipeline drugs by the Route of Administration. Products have been categorized under various ROAs such as
Oral
Intramuscular
Intradermal
Molecule Type
Products have been categorized under various Molecule types such as
Small molecules
Vaccines
Monoclonal antibodies
Product Type

Drugs have been categorized under various product types like Mono, Combination, and Mono/Combination.
Learn more about the treatment market for Lassa Fever @ https://www.delveinsight.com/report-store/lassa-fever-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=dpr

Learn more about the Key Companies and Emerging Therapies in the Lassa Fever Market @https://www.delveinsight.com/sample-request/lassa-fever-pipeline-insight utm_source=openpr&utm_medium=pressrelease&utm_campaign=dpr

Table of Contents
Key Insights
Lassa Fever Introduction
Executive Summary of Lassa Fever
Disease Background and Overview
Lassa Fever Epidemiology and patient population
Lassa Fever Emerging Therapies
Lassa Fever Market Outlook
Lassa Fever Market Access and Reimbursement of Therapies
Lassa Fever Market Drivers
Lassa Fever Market Barriers
Appendix
Lassa Fever Report Methodology
DelveInsight Capabilities
Disclaimer

Learn about the detailed offerings of the Lassa Fever Market Outlook report @ https://www.delveinsight.com/report-store/lassa-fever-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=dpr

Trending Reports By DelveInsight:

Functional Constipation Market
https://www.delveinsight.com/report-store/chronic-constipation-market

Lebers Hereditary Optic Neuropathy Lhon Market https://www.delveinsight.com/report-store/lebers-hereditary-optic-neuropathy-lhon-market

Gastric Neuroendocrine Tumors Market
https://www.delveinsight.com/report-store/gastric-neuroendocrine-tumors-market

Immune Thrombocytopenic Purpura Market
https://www.delveinsight.com/report-store/immune-thrombocytopenia-itp-market

Visceral Pain Associated With GI Disorders Market
https://www.delveinsight.com/report-store/visceral-pain-associated-with-gi-disorders-market

Bullous Pemphigoid Market
https://www.delveinsight.com/report-store/bullous-pemphigoid-market

Cyclin-dependent Kinase-like 5 Deficiency Disorder Market https://www.delveinsight.com/infographics/cyclin-dependent-kinase-like-5-cdkl5-deficiency-disorder-market

Myocarditis Market
https://www.delveinsight.com/report-store/myocarditis-market

Recurrent Blood Clots Market
https://www.delveinsight.com/report-store/recurrent-blood-clots-thrombophilia-market

Zollinger-ellison Syndrome Market
https://www.delveinsight.com/report-store/zollinger-ellison-syndrome-market

Age-related Hearing Loss Medical Device Market
https://www.delveinsight.com/blog/age-related-hearing-loss-device-market

Heart Sounds Sensors Market
https://www.delveinsight.com/report-store/heart-sounds-sensors-electronic-stethoscope-market

Hypoplastic Left Heart Syndrome Hlhs Market
https://www.delveinsight.com/report-store/hypoplastic-left-heart-syndrome-market

Infectious Arthritis/Septic Arthritis Market
https://www.delveinsight.com/report-store/infectious-arthritisseptic-arthritis-market

Plasmacytoma Market
https://www.delveinsight.com/report-store/plasmacytoma-market

Agoraphobia Market
https://www.delveinsight.com/report-store/agoraphobia-market

Clinically Isolated Syndrome CIS Market
https://www.delveinsight.com/report-store/clinically-isolated-syndrome-cis-market

Fucosidosis Market
https://www.delveinsight.com/report-store/fucosidosis-market

Major Depressive Disorder Market
https://www.delveinsight.com/report-store/major-depressive-disorder-market

Neuronal Ceroid-lipofuscinoses Market
https://www.delveinsight.com/report-store/neuronal-ceroid-lipofuscinoses-cln1-disease-market

Orthotic Devices Market
https://www.delveinsight.com/report-store/orthotic-devices-market

DelveInsight Business Research LLP
Adya Kaul
info@delveinsight.com
https://www.delveinsight.com

DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance. It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate business growth and overcome challenges with a practical approach.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Lassa Fever Pipeline| Clinical Trials, Key Companies - Themis Bioscience, Inovio, GeoVax, GloBavir biosciences, and Kineta Inc here

News-ID: 3276996 • Views:

More Releases from DelveInsight Business Research LLP

Pharmaceutical Contract Manufacturing Market Forecast Report 2032: Size, Share, and Strategic Insights by DelveInsight
Pharmaceutical Contract Manufacturing Market Forecast Report 2032: Size, Share, …
DelveInsight's Pharmaceutical Contract Manufacturing Market Insights Report 2032 provides the current and forecast market analysis, individual leading Pharmaceutical Contract Manufacturing Companies market shares, challenges, Pharmaceutical Contract Manufacturing Market Drivers, barriers, trends, and key market Pharmaceutical Contract Manufacturing companies in the market. To read more about the latest highlights related to the Pharmaceutical Contract Manufacturing Market, get a snapshot of the key highlights entailed in the Market Report @ https://www.delveinsight.com/sample-request/pharmaceutical-contract-manufacturing-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr Key
Pharmaceuticals Market Forecast Report 2032: Size, Share, and Strategic Insights by DelveInsight
Pharmaceuticals Market Forecast Report 2032: Size, Share, and Strategic Insights …
DelveInsight's Pharmaceuticals Market Insights Report 2032 provides the current and forecast market analysis, individual leading Pharmaceuticals Companies market shares, challenges, Pharmaceuticals Market Drivers, barriers, trends, and key market Pharmaceuticals companies in the market. To read more about the latest highlights related to the Pharmaceuticals Market, get a snapshot of the key highlights entailed in the Market Report @ https://www.delveinsight.com/sample-request/pharmaceutical-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr Key Takeaways from the Pharmaceuticals Market Report • In July 2025, Sanofi announced the
Checkpoint Inhibitors Competitive Landscape Report 2025: Emerging Therapies, Leading Companies, and Future Outlook
Checkpoint Inhibitors Competitive Landscape Report 2025: Emerging Therapies, Lea …
DelveInsight's, "Checkpoint Inhibitors Competitive landscape 2025" report provides comprehensive insights about 50+ companies and 60+ drugs in Checkpoint Inhibitors Competitive landscape. It covers the Checkpoint Inhibitors Therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Explore the full insights into the evolving Checkpoint Inhibitors Pipeline and discover which companies are leading the innovation race @ Checkpoint Inhibitors Competitive
Surgical Simulation Market Forecast Report 2032: Size, Share, and Strategic Insights by DelveInsight
Surgical Simulation Market Forecast Report 2032: Size, Share, and Strategic Insi …
DelveInsight's Surgical Simulation Market Insights Report 2032 provides the current and forecast market analysis, individual leading Surgical Simulation Companies market shares, challenges, Surgical Simulation Market Drivers, barriers, trends, and key market Surgical Simulation companies in the market. To read more about the latest highlights related to the Surgical Simulation Market, get a snapshot of the key highlights entailed in the Market Report @ https://www.delveinsight.com/sample-request/surgical-simulation-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr Key Takeaways from the Surgical Simulation Market

All 5 Releases


More Releases for Lassa

Lassa Fever Market Insights Highlight Expanding Outlook Till 2034, DelveInsight …
The Lassa Fever market is expected to surge due to the disease's increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Lassa Fever pipeline products will significantly revolutionize the Lassa Fever market dynamics. DelveInsight's "Lassa Fever Market Insights, Epidemiology, and Market Forecast-2034′′ report offers an in-depth understanding of the Lassa Fever, historical and forecasted epidemiology as well as the Lassa Fever market trends in the United
Lassa fever market is expected to reach USD 210 million by 2034
Lassa fever is an acute viral hemorrhagic illness caused by the Lassa virus, an arenavirus endemic to West Africa. It spreads primarily through contact with food or household items contaminated by rodents (Mastomys natalensis) or through person-to-person transmission in healthcare settings. With an estimated 100,000-300,000 infections annually and ~5,000 deaths, Lassa fever poses a serious public health threat. Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/71747 Currently, there is no approved
Lassa Fever Treatment Market, Unraveling Innovations and Strategic Solutions for …
Overview of the Lassa Fever Treatment Market The global Lassa fever treatment market has been rapidly gaining traction as the prevalence of this viral disease continues to impact public health worldwide. Lassa fever is an acute viral hemorrhagic disease caused by the Lassa virus, primarily transmitted by rodents, particularly the Mastomys species, which are found in parts of West Africa. While Lassa fever has a relatively low mortality rate compared to
Lassa Fever Market Size, Analysis, Industry Statistics and Latest Insights Till …
Market Overview: The lassa fever market is expected to exhibit a CAGR of 3.84% during 2023-2033. The lassa fever market report offers a comprehensive analysis of the market in the United States, EU5 (including Germany, Spain, Italy, France, and the United Kingdom), and Japan. It covers aspects such as treatment methods, drugs available in the market, drugs in development, the market share of various therapies, and the market's performance in the
Lassa Fever Treatment Market Trends, Growth Development, Key Opportunity, Applic …
When building an excellent  Lassa Fever Treatment Market report, myriad of objectives of the marketing research have been kept in mind. All the data and statistics included in this report is derived from the reliable sources only e.g. journals or white papers of companies etc. This market research report contains several parameters which are thoroughly studied by the experts. This market analysis report provides with a thorough analysis of market
Lassa Fever Market to Witness Growth by 2032, Estimates DelveInsight
DelveInsight's "Lassa Fever Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of Lassa Fever Market , historical and forecasted epidemiology as well as the Lassa Fever Market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom), and Japan. The Lassa Fever Market report provides current treatment practices, emerging drugs, the market share of the individual therapies, and the current and forecasted Lassa Fever